1. Conducted 11 private equity research activities covering biopharmaceuticals, medical devices, and Next-generation sequencing research devices.2. Compiled 18 market opportunity analyses; Created 8 databases of market competitors’ financial information.3. Analyzed cross-border partnership trends of biopharmaceuticals including antibodies, and mRNA therapies, across all therapeutic areas; Performed research in both English and Chinese; Presented data for investor presentations.

1. Gene targets research; Target-related therapeutic area and potential treatment research.2. Document consulting of targets’ chemical properties and potential uses for drug development.